Lower GI Distress in an HIV-Positive Young Man

DDW 2025. Colonoscopic delivery of fecal therapy prevented recurrent C. diff infection in 95% of participants for 8 weeks, with mild GI adverse events reported by <10%.

Recurrent C difficile requires pulse vancomycin therapy; fecal microbiota transplant shows promise.

Your daily dose of the clinical news you may have missed.

Approximately 25% of those infected with HIV are unaware of their positive status. The USPSTF says universal screening can help reduce disease burden.

CROI 2025: Increased HPV vaccine coverage could reduce HIV cases by thousands, according to a new study.

The impact of food elimination diets on medication previously was unknown, according to new research presented at AAAAI 2025.